STOCK TITAN

[144] United States Cellular Corporation 5.500% Senior Notes due 2070 SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Form 144 notice for United States Cellular Corporation (UZE). The filer reports a proposed sale of 1,960 common shares, acquired as vested RSAs on 08/01/2025 with payment characterized as equity compensation. The aggregate market value of the shares at reporting is $148,372.00, against 53,000,000 shares outstanding. The seller lists an approximate sale date of 08/18/2025 and the sale is to be executed through Charles Schwab Corp. on the NYSE. The filing states there were no securities sold by the seller in the past three months and includes the seller's certification about lack of undisclosed material information.

Avviso Form 144 per United States Cellular Corporation (UZE). Il dichiarante segnala la proposta di vendita di 1.960 azioni ordinarie, acquisite come RSAs maturate il 01/08/2025 e pagate come compenso in azioni. Il valore di mercato complessivo delle azioni al momento della segnalazione è di $148.372,00, su un totale di 53.000.000 azioni in circolazione. Il venditore indica una data approssimativa di vendita del 18/08/2025 e l’operazione sarà eseguita tramite Charles Schwab Corp. sul NYSE. La comunicazione dichiara che il venditore non ha venduto titoli negli ultimi tre mesi e include la sua certificazione sull’assenza di informazioni materiali non divulgate.

Aviso Formulario 144 para United States Cellular Corporation (UZE). El declarante informa sobre la propuesta de venta de 1.960 acciones ordinarias, adquiridas como RSAs devengadas el 01/08/2025 y pagadas como compensación en acciones. El valor de mercado agregado de las acciones al momento del informe es de $148,372.00, frente a 53,000,000 acciones en circulación. El vendedor indica una fecha aproximada de venta del 18/08/2025 y la venta se realizará a través de Charles Schwab Corp. en la NYSE. La presentación declara que el vendedor no vendió valores en los últimos tres meses e incluye la certificación del vendedor sobre la ausencia de información material no divulgada.

United States Cellular Corporation (UZE)용 Form 144 통지. 제출인은 1,960 보통주 매각 예정임을 보고했으며, 해당 주식은 2025-08-01완전 취득된 RSA로 취득되었고 지급 형태는 주식 보상으로 분류됩니다. 보고 시점의 주식 총 시가총액은 $148,372.00이고, 발행 주식 수는 53,000,000주입니다. 매도인은 약식 매각 예정일을 2025-08-18로 기재했으며 매매는 NYSE에서 Charles Schwab Corp.를 통해 이루어질 예정입니다. 보고서에는 매도인이 지난 3개월 동안 매도한 증권이 없음을 기재하고 있으며, 미공개 중요 정보가 없음을 확인하는 인증서가 포함되어 있습니다.

Avis Formulaire 144 pour United States Cellular Corporation (UZE). Le déposant signale une vente projetée de 1 960 actions ordinaires, acquises en tant que RSAs acquises le 01/08/2025 et dont le paiement est qualifié de rémunération en actions. La valeur marchande agrégée des actions au moment du rapport est de 148 372,00 $, sur 53 000 000 actions en circulation. Le vendeur indique une date de vente approximative au 18/08/2025 et la transaction sera exécutée via Charles Schwab Corp. sur le NYSE. Le dépôt précise qu’aucun titre n’a été vendu par le vendeur au cours des trois derniers mois et inclut la certification du vendeur quant à l’absence d’informations matérielles non divulguées.

Formular 144-Mitteilung für United States Cellular Corporation (UZE). Der Einreichende meldet einen geplanten Verkauf von 1.960 Stammaktien, erworben als gevestete RSAs am 01.08.2025, mit der Zahlung als Aktienvergütung. Der aggregierte Marktwert der Aktien zum Zeitpunkt der Meldung beträgt $148.372,00, bei insgesamt 53.000.000 ausstehenden Aktien. Der Verkäufer gibt ein ungefähres Verkaufsdatum von 18.08.2025 an; der Verkauf soll über Charles Schwab Corp. an der NYSE ausgeführt werden. Die Einreichung besagt, dass der Verkäufer in den letzten drei Monaten keine Wertpapiere verkauft hat und enthält die Bestätigung des Verkäufers über das Fehlen nicht offengelegter wesentlicher Informationen.

Positive
  • Clear disclosure of number of shares to be sold (1,960) and aggregate market value ($148,372.00)
  • Transaction source disclosed as vested RSAs with equity compensation payment characterization
  • Broker and market specified: Charles Schwab Corp. on the NYSE, with an approximate sale date of 08/18/2025
  • Seller attestation that there is no undisclosed material adverse information and statement that no securities were sold in the past three months
Negative
  • Filer contact and issuer identification fields appear incomplete or blank in the provided content
  • Filing contains minimal context about the seller's identity or any trading plan details beyond the basic attestation

Insights

TL;DR: A small equity-compensation share sale is planned and appears routine, with limited direct impact on company capital structure.

The notice documents a proposed disposition of 1,960 common shares obtained as vested restricted stock awards on 08/01/2025. The transaction is scheduled through Charles Schwab on the NYSE on or about 08/18/2025, with an aggregate reported market value of $148,372.00. The filing reports no sales by the holder in the last three months and includes the standard attestation of no undisclosed material information. From a capital-markets perspective, this appears to be an individual insider's routine sale of vested equity rather than a corporate financing event.

TL;DR: Document is a standard compliance filing for insider sales tied to equity compensation, emphasizing required attestations.

The Form 144 discloses that the securities to be sold were acquired as vested RSAs and that the seller certifies absence of undisclosed material information. The form lists the broker and an approximate sale date, and explicitly notes no securities sold in the prior three months by the same person. The filing fulfills Rule 144 notification requirements and includes the statutory warning about intentional misstatements. No governance red flags or material compliance exceptions are apparent from the notice itself.

Avviso Form 144 per United States Cellular Corporation (UZE). Il dichiarante segnala la proposta di vendita di 1.960 azioni ordinarie, acquisite come RSAs maturate il 01/08/2025 e pagate come compenso in azioni. Il valore di mercato complessivo delle azioni al momento della segnalazione è di $148.372,00, su un totale di 53.000.000 azioni in circolazione. Il venditore indica una data approssimativa di vendita del 18/08/2025 e l’operazione sarà eseguita tramite Charles Schwab Corp. sul NYSE. La comunicazione dichiara che il venditore non ha venduto titoli negli ultimi tre mesi e include la sua certificazione sull’assenza di informazioni materiali non divulgate.

Aviso Formulario 144 para United States Cellular Corporation (UZE). El declarante informa sobre la propuesta de venta de 1.960 acciones ordinarias, adquiridas como RSAs devengadas el 01/08/2025 y pagadas como compensación en acciones. El valor de mercado agregado de las acciones al momento del informe es de $148,372.00, frente a 53,000,000 acciones en circulación. El vendedor indica una fecha aproximada de venta del 18/08/2025 y la venta se realizará a través de Charles Schwab Corp. en la NYSE. La presentación declara que el vendedor no vendió valores en los últimos tres meses e incluye la certificación del vendedor sobre la ausencia de información material no divulgada.

United States Cellular Corporation (UZE)용 Form 144 통지. 제출인은 1,960 보통주 매각 예정임을 보고했으며, 해당 주식은 2025-08-01완전 취득된 RSA로 취득되었고 지급 형태는 주식 보상으로 분류됩니다. 보고 시점의 주식 총 시가총액은 $148,372.00이고, 발행 주식 수는 53,000,000주입니다. 매도인은 약식 매각 예정일을 2025-08-18로 기재했으며 매매는 NYSE에서 Charles Schwab Corp.를 통해 이루어질 예정입니다. 보고서에는 매도인이 지난 3개월 동안 매도한 증권이 없음을 기재하고 있으며, 미공개 중요 정보가 없음을 확인하는 인증서가 포함되어 있습니다.

Avis Formulaire 144 pour United States Cellular Corporation (UZE). Le déposant signale une vente projetée de 1 960 actions ordinaires, acquises en tant que RSAs acquises le 01/08/2025 et dont le paiement est qualifié de rémunération en actions. La valeur marchande agrégée des actions au moment du rapport est de 148 372,00 $, sur 53 000 000 actions en circulation. Le vendeur indique une date de vente approximative au 18/08/2025 et la transaction sera exécutée via Charles Schwab Corp. sur le NYSE. Le dépôt précise qu’aucun titre n’a été vendu par le vendeur au cours des trois derniers mois et inclut la certification du vendeur quant à l’absence d’informations matérielles non divulguées.

Formular 144-Mitteilung für United States Cellular Corporation (UZE). Der Einreichende meldet einen geplanten Verkauf von 1.960 Stammaktien, erworben als gevestete RSAs am 01.08.2025, mit der Zahlung als Aktienvergütung. Der aggregierte Marktwert der Aktien zum Zeitpunkt der Meldung beträgt $148.372,00, bei insgesamt 53.000.000 ausstehenden Aktien. Der Verkäufer gibt ein ungefähres Verkaufsdatum von 18.08.2025 an; der Verkauf soll über Charles Schwab Corp. an der NYSE ausgeführt werden. Die Einreichung besagt, dass der Verkäufer in den letzten drei Monaten keine Wertpapiere verkauft hat und enthält die Bestätigung des Verkäufers über das Fehlen nicht offengelegter wesentlicher Informationen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for UZE disclose?

The Form 144 discloses a proposed sale of 1,960 common shares acquired as vested RSAs on 08/01/2025, with an aggregate market value of $148,372.00, to be sold approximately on 08/18/2025 through Charles Schwab on the NYSE.

How were the shares being sold acquired according to the filing?

The shares were acquired as vested restricted stock awards (RSAs) on 08/01/2025, with consideration characterized as equity compensation.

Does the filing report any securities sold by the same person in the past three months?

No. The Form 144 explicitly states Nothing to Report for securities sold during the past three months by the person for whose account the sale is proposed.

When is the proposed sale date listed in the Form 144?

The approximate date of sale listed in the filing is 08/18/2025.

Which broker is named to execute the proposed sale?

The filing names Charles Schwab Corp., 3000 Schwab Way, Westlake TX 76262 as the broker.
United States

NYSE:UZE

UZE Rankings

UZE Latest SEC Filings

UZE Stock Data

20.00M
Wireless Telecommunications Carriers (except Satellite)
Radiotelephone Communications
Link
CHICAGO